Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Non-interventional, Observational Study in Patients With IBD Receiving IV or SC Vedolizumab Therapy to Observe Route of Administration Choices and Outcomes

NCT04885920 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT04885920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04885920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Non-interventional, Observational Study in Patients With IBD Receiving IV or SC Vedolizumab Therapy to Observe Route of Administration Choices and Outcomes
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
February 22, 2022
Completion date
March 12, 2024
Enrollment
120 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

colitis, ulcerative, crohns disease, inflammatory bowel diseases